▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #65 by analyst upside · 2026-09-05
AMIX
Autonomix Medical, Inc.
Healthcare · Market Cap $4M · P/E 0x
ANALYST PRICE TARGET
+1181.0%
implied upside to consensus target
Current Price $4.59
Consensus Target $58.8
Bull Target $75.6
Bear Target $42.0
Analysts Covering 2
ANALYST CONSENSUS - STRONG BUY
Strong Buy
1
Buy
1
Hold
0
Sell
0
52-Week Low $2.44
52-Week High $32.55
YTD Return -59.3%
FUNDAMENTALS
Market Cap $4M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-30.32
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $2.44
52-Week High $32.55
Current Price $4.59
Bear Target $42.0
Bull Target $75.6
● Now $4.59 ● Target $58.8
TRADING DATA
Avg Volume 4.5M
YTD Return -59.3%
Analyst Count 2
Consensus Strong Buy
Upside to Target +1181.0%
Last Updated 2026-09-05

ANALYST SUMMARY

Autonomix Medical, Inc. (AMIX) is currently trading at $4.59 with a Wall Street consensus price target of $58.8, implying potential upside of 1181.0% over the next 12 months. 2 analysts currently cover AMIX, with a consensus rating of Strong Buy - 100% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $75.6, while the most cautious has a target of $42.0.

AMIX operates in the Healthcare sector with a market capitalisation of $4M. The stock is down 59.3% year-to-date and is currently trading near the lower end of its 52-week range of $2.44 – $32.55.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CNSY +1206.7%
Cerenome, Inc.
$21M · P/E 1.0x · Buy
ETST +1011.1%
Earth Science Tech, Inc.
$26M · P/E 9.0x · Hold
TOVX +888.1%
Theriva Biologics, Inc.
$12M · P/E 0.2x · Strong Buy
VXRT +566.7%
Vaxart, Inc.
$122M · P/E 2.9x · Buy
DWTX +511.4%
Dogwood Therapeutics, Inc.
$78M · P/E 1.2x · Strong Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for AMIX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Maxim Group - Reiterated
Buy → Buy 2026-02-17 28% win rate (40 calls)
Maxim Group ● Initiated
Buy 2025-04-29 28% win rate (40 calls)
Ladenburg Thalmann ● Initiated
Buy 2024-09-03 25% win rate (8 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
35
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
25/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →